Seminars in Thrombosis and Hemostasis

Papers
(The TQCC of Seminars in Thrombosis and Hemostasis is 7. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-12-01 to 2025-12-01.)
ArticleCitations
75
47
2021 Eberhard F. Mammen Award Announcements: Part II—Young Investigator Awards44
The Next, Next-Generation of Sequencing, Promising to Boost Research and Clinical Practice40
Effects of Inflammation on Hemostasis in Acutely Ill Patients with Liver Disease34
Cancer-Associated Thrombosis: Implications toward Health-Related Quality of Life34
Hemostatic Manifestations of Invasive Fungal Infections: A Comprehensive Review of Pathophysiological Mechanisms in Sepsis-Induced Hemostatic Disturbances, with a Focus on the Neonatal Population32
Prevention of Venous Thromboembolism in Medical Patients with Thrombocytopenia or with Platelet Dysfunction: The Last 10 Years31
Role of Platelets in Rheumatic Chronic Autoimmune Inflammatory Diseases31
Fright of Long-Haul Flights: Focus on Travel-Associated Thrombosis30
Drug–Drug Interactions in the Treatment of Cancer-Associated Venous Thromboembolism with Direct Oral Anticoagulants30
Tissue Plasminogen Activator in Central Nervous System Physiology and Pathology: From Synaptic Plasticity to Alzheimer's Disease29
Thrombosis in Antiphospholipid Syndrome: Current Perspectives and Challenges in Laboratory Testing for Antiphospholipid Antibodies29
Molecular Mimicry between hPF4 and SARS-CoV-2 Spike Protein: Comment29
Application of ACR/EULAR Classification Criteria in Real Life: Thrombotic Patients Positive for Lupus Anticoagulant Only29
Thrombotic Antiphospholipid Syndrome and Direct Oral Anticoagulants: Unmet Needs and Review of the Literature29
Resonant Acoustic Rheometry to Measure Coagulation Kinetics in Hemophilia A and Healthy Plasma: A Novel Viscoelastic Method28
Lupus Anticoagulant-hypoprothrombinemia Syndrome: A Review Enriched by a New Particular Patient27
Enhanced Half-Life Recombinant Factor VIII Concentrates for Hemophilia A: Final Results from Extension Studies26
Platelet Function Testing: Update and Future Directions26
Testing for Lupus Anticoagulants24
Platelet Activation and Thrombosis in COVID-1923
Pulmonary Embolism in Patients with COVID-19: Comparison between Different Care Settings21
Platelet Function: Acute versus Chronic Responses to Physical Exercise: A Review21
Evolution of Clinical Trials in Anticoagulation for Sepsis: Bridging Past to Future21
Fifty Years of Fibrinogen Structure and Function21
Editorial Compilation—XIII21
Autoantibodies in Autoimmune Coagulation Factor Deficiencies: A Review of Inhibitory and Clearance-Accelerating Mechanisms from Japanese Practice20
Gene Therapy for Hemophilia B: Achievements, Open Issues, and Perspectives20
How Do Laboratories Perform von Willebrand Disease Diagnostics and Classification of von Willebrand Disease Patients? Results from External Quality Data and an International Survey19
Evolving Knowledge on Primary and Secondary Prevention of Venous Thromboembolism in Carriers of Hereditary Thrombophilia: A Narrative Review19
Modulating Immune Responses: The Double-Edged Sword of Platelet CD40L17
The History of Rare Bleeding Disorders17
Toward 50 Years of Seminars in Thrombosis and Hemostasis17
Anti-platelet Factor 4 Antibody-Mediated Disorders: An Updated Narrative Review17
Comprehensive Mendelian Randomization Analysis of Smoking and Its Effects on Venous Thromboembolism16
Investigating a Signal of Acquired Hemophilia Associated with COVID-19 Vaccination: A Systematic Case Review16
2022 Eberhard F. Mammen Award Announcements: Part I—Most Popular Articles16
Magnetic Resonance Screening for Cerebral Venous Sinus Thrombosis during Treatment with Pegaspargase15
Association between Severe Acute Respiratory Syndrome Coronavirus 2 Infection (Coronavirus Disease 2019) and Lupus Anticoagulant-Hypoprothrombinemia Syndrome: A Case Report and Literature Assessment15
Neurocoagulation from a Mechanistic Point of View in the Central Nervous System15
Platelet Function in Patients with Disseminated Intravascular Coagulation: Potential Markers for Improving DIC Diagnosis?14
Renal Bleeding in Patients with Impairment: A Current Perspective14
14
Bernard–Soulier Syndrome: A Review of Epidemiology, Molecular Pathology, Clinical Features, Laboratory Diagnosis, and Therapeutic Management14
50 Years of Pediatric Hemostasis: Knowledge, Diagnosis, and Treatment14
In Search of the Perfect Thrombosis and Bleeding-Associated Cancer Scale14
Celebrating 50 Years of Seminars in Thrombosis and Hemostasis—Part III14
From Ink Pens to Computers: A Personal Look Back at Landmark Changes during 5 Decades as a Clinical Laboratory Scientist in U.S. Hemostasis Laboratories14
14
Emicizumab in Type 3 von Willebrand Disease: Report of a Case with an Alloantibody and Literature Review13
External Quality Assessment Data for Investigation of von Willebrand Disease: Focus on Relative Utility of Contemporary Functional von Willebrand Factor Assays. The United Kingdom National External Qu13
Automation in Platelet Function Testing: Current Challenges and Future Directions13
Laboratory Testing for the Evaluation of Phenotypic Activated Protein C Resistance13
Mendelian Randomization Provides No Evidence for the Bidirectional Relationship between Type 2 Diabetes and Venous Thromboembolism in East Asians and African Americans13
Use of Present-on-Admission Indicators to Improve Accuracy of Pulmonary Embolism Identification from Electronic Health Record Data13
Seminars in Thrombosis and Hemostasis: 2024 Impact Factor, Most Highly Cited Papers, and Other Journal Metrics13
Venous Thromboembolism in Children: The Rivaroxaban Experience12
Lipopolysaccharide and Coagulation Factor XII: Biophysics of Contact Activation in Infection12
Gene Therapy in Hemophilia A: Achievements, Challenges, and Perspectives12
Neutrophil Extracellular Traps: At the Interface of Thrombosis and Comorbidities12
Colchicine as a Modulator of Platelet Function: A Systematic Review12
Heparin-Like Anticoagulant: First Case Described in a Metastatic Biliopancreatic Cancer12
Strength of Anticoagulation in Moderate to Severe COVID-19 Illness: In Medio Stat Virtus?12
International Council for Standardization in Haematology Guidance for New Lot Verification of Coagulation Reagents, Calibrators, and Controls12
The Erythrocyte–ROS Axis in Thrombosis and Hemostasis12
A Brief History of Hemostasis and Thrombosis at the Mayo Clinic12
12
Clinical, Laboratory, and Molecular Aspects of Factor V Deficiency12
Comparative Study of Venous Thromboembolic Prophylaxis Strategies for Patients with Ischemic Stroke: A Systematic Review and Network Meta-Analysis of Randomized Controlled Trials12
COVID-19 Vaccine-Associated Immune Thrombosis and Thrombocytopenia (VITT): Diagnostic Discrepancies and Global Implications11
Tranexamic Acid and Its Potential Anti-Inflammatory Effect: A Systematic Review11
Dosing Intensity of Anticoagulants for the Prevention and Treatment of Venous Thromboembolism and the Prevention of Stroke in Atrial Fibrillation: Why is There a Difference?11
Mortality from Pulmonary Embolism in Patients with Post-Coronavirus Disease Syndrome11
Bleeding Scoring Systems in Neonates: A Systematic Review11
A Historical Perspective on the Reversal of Anticoagulants11
Impact of Hematocrit on Coagulation Measured by Rotational Thromboelastometry in Healthy Subjects and Patients with Polycythemia11
Comparison of Platelet Function Tests for Long-Term Cardiovascular Events after Percutaneous Coronary Interventions11
Optimizing Venous Stenting: Consensus Recommendations for Enhanced Management of Lower Extremity Deep Vein Thrombosis11
Editorial Compilation XIV11
Pulmonary Embolism-Related Mortality in Femur Fracture Patients: A Recent Retrospective Epidemiological Analysis11
Evaluating Diagnostic Algorithms for Heparin-Induced Thrombocytopenia using Two Combined Automated Rapid Immunoassays10
Risk Factors for Left Ventricular Thrombus Formation in Patients with Dilated Cardiomyopathy10
Activated Partial Thromboplastin Time and Prothrombin Time Mixing Studies: Current State of the Art10
Editorial Compilation XI10
Thrombin Generation Assays: What are the Current Clinical Applications?10
COVID-19 and Anticoagulant Use: Did the Pandemic Push DOACs Ahead of Warfarin?10
Clinical Features of Antiphospholipid Syndrome with Intracardiac Mass10
Past, Present, and Future Perspectives of Plasminogen Activator Inhibitor 1 (PAI-1)10
The Applicability of Thromboelastography in Acute Ischemic Stroke: A Literature Review10
Cancer-Associated Thrombosis and Beyond: Biomarkers, Treatments, and Cancer-Hemostasis Interactions10
Do we Have the Gut to Beat Thrombosis?10
Precision Medicine in Rare Bleeding Disorders10
A Perspective on How Fibrinaloid Microclots and Platelet Pathology May be Applied in Clinical Investigations10
10
Hematohidrosis in 15th Century Renaissance Art and a Review of Modern Literature9
National Early Warning Score-2 for Identification of Patients with Intermediate-High-Risk Pulmonary Embolism9
The Role of Platelets in Atherosclerosis: A Historical Review9
Current Diagnosis of von Willebrand Disease in Italy: 3 Years Following the Release of the International Guidelines9
Pleiotropic Effects of Heparin and its Monitoring in the Clinical Practice9
Platelet Physiology9
Non-factor Therapies for Hemophilia: Achievements and Perspectives9
Hemostasis Testing in the Emergency Department: A Narrative Review9
NETosis in Acute Thrombotic Disorders9
The Pathophysiological Role of Platelet-Derived Extracellular Vesicles9
Safety and Efficacy of Therapeutic Anticoagulation with Subcutaneous Unfractionated Heparin in Patients with Renal Failure9
9
Transitioning of Patients from Direct-Acting Oral Anticoagulant to Heparin: Impact on Laboratory Testing9
Molecular Mimicry between hPF4 and SARS-CoV-2 Spike Protein: Response to Comment9
Current Understandings on Biological Characteristics of Thrombolytics in Acute Ischemic Stroke8
Laboratory Testing for ADAMTS13 for Thrombotic Thrombocytopenia Purpura and Beyond8
Why Does Rivaroxaban Not Work in Severe Mitral Stenosis?8
Emerging Use of Viscoelastography in Thrombosis and Hemostasis: A Challenge to Conventional Coagulation Tests? Part I: The Use of Thromboelastography and Thromboelastometry in the Assessment of Hemost8
Laboratory Testing for Fibrinogen Disorders: From Routine Investigations to Research Studies8
Increased HDL-C Values and Mortality: Revolutionizing a Historical Paradigm?8
8
2022 Eberhard F. Mammen Award Announcements: Part II—Young Investigator Awards8
Internal Quality Control in Hemostasis Assays8
Crucial Stepping Stones in Platelet History8
Factor Replacement Treatment for Hemophilia A: Achievements and Perspectives8
PFA-100 System: A New Method for Assessment of Platelet Dysfunction8
Discordant High Activated Partial Thromboplastin Time Relative to Anti-Xa Values in Hospitalized Patients is an Independent Risk Factor for Increased 30-day Mortality8
It Is Proposed That Cardiovascular Functions are Regulated by the Status of Ecto-phosphoproteins Orchestrated by Platelets7
Advances in the Management of Coagulopathy in Trauma: The Role of Viscoelastic Hemostatic Assays across All Phases of Trauma Care7
Next-Generation Sequencing and Emerging Technologies*7
New Seminars in Thrombosis and Hemostasis (STH) 2021 Impact Factor, Most Highly Cited Papers, and Other Journal Metrics7
Clinical, Laboratory, and Molecular Aspects of Factor VII Deficiency7
D-dimers—“Normal” Levels versus Elevated Levels Due to a Range of Conditions, Including “D-dimeritis,” Inflammation, Thromboembolism, Disseminated Intravascular Coagulation, and COVID-197
The More Recent History of Hemophilia Treatment7
7
Viscoelastic Management of Coagulopathy during the Perioperative Period of Liver Transplantation7
7
Evolution of Antiphospholipid Syndrome7
One Hundred Years of Congenital Fibrinogen Disorders7
Advanced Treatment of Hemodynamically Unstable Acute Pulmonary Embolism and Clinical Follow-up7
Application of Activators Ecarin and Factor Xa in Thrombelastography for Measurement of Anticoagulant Effect of Direct Oral Anticoagulants Using TEG 50007
0.10576105117798